GoldBamboo.com - Knowledge is strong medicine
  

Homelessness Prevention: Psychiatric Care with Representative Payeeship - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Organic Mental Disorders

 




Clinical Trial: Homelessness Prevention: Psychiatric Care with Representative Payeeship

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs

Purpose

The purpose of this application is to determine, in a randomized clinical trial, whether a community-based representative payee program coordinated with VA psychiatric community care (CO-RP) can be more clinically effective and less costly than customary treatment for veterans who have no representative payee (RP) or RP that is not coordinated with their care.

Condition Treatment or Intervention
Mental Disorders
 Behavior: Coordinated Representative Payeeship with Case Management

MedlinePlus related topics:  Mental Health

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Dose Comparison, Parallel Assignment

Further Study Details: 

Expected Total Enrollment:  240

Study start: January 2001;  Study completion: December 2003

Two hundred and forty study subjects would: 1) meet the criteria for enrollment in the CO-RP program, i.e., chiefly, at risk for homelessness due to money management problems; 2) have a serious mental illness, possibly with a co-occurring substance use disorder; and 3) be engaged with the VA mental health treatment system. The study would assess utilization of services to examine the appropriateness of causal inferences as well to enable cost comparisons. It would also describe and document the implementation of CO-RP versus customary care. The implementation measures will assess dosage and enable replicability if outcomes are positive or recommendations for improvement if outcomes are negative or equivocal. The hypotheses to be tested are listed below with the measures of the constructs in parentheses.

The hypotheses are that, relative to customary care control group participants, the CO-RP participants will experience: 1) improved housing stability (Residential Follow Back Calendar and American Housing Survey, adapted), 2) improved financial stability (Money Management and Financial Victimization Questionnaire), 3) improved health-related quality of life, including less mental illness symptomatology (SF-36V, Colorado Symptom Index), 4) less substance abuse and dependence (Drug and Alcohol Follow Back Calendar, Addiction Severity Index (ASI), Drug and Alcohol Use Scales), and 5) reduced hospitalization and ER use with increased social and outpatient services for a net reduced cost (VA data bases and Treatment Services Review). To enable testing of treatment group by subgroup status interaction effects, the sample will be blocked on: substance abuse versus non-substance abuse using ASI criterion; low or high (IPCC) level of case management; low or high income split at the current mean income of $717. The outcomes will be analyzed with random effects analysis of covariance using data from a baseline pretest and six and twelve month posttests. The intervention is relevant to the VA since it involves an enhancement to current treatment that is rarely used but is potentially available nationwide, e.g., through agencies such as those used by the Social Security Administration. Also, CO-RP requires modest additional resources while having the potential to promote the more appropriate use of benefits, improve the outcomes of care, and reduce utilization of more expensive services for a possible net reduction in costs.

Eligibility

Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • Severe mental illness
  • Inability to manage money
  • VA patient

Location Information


Illinois
      Edward Hines, Jr. VA Hospital, Hines,  Illinois,  60141-5000,  United States

More Information

Study ID Numbers:  IIR 98-154
Record last reviewed:  March 2005
Last Updated:  March 16, 2005
Record first received:  March 27, 2003
ClinicalTrials.gov Identifier:  NCT00057161
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Organic Mental Disorders.

December 4, 2009



Page Updated: December 9, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.